Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Period Progress
Go back to Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Period Progress| Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) | Delayed: 286.41 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $286.41 | 52 Week High | $109.10 | |||
| Open | $286.41 | 52 Week Low | $31.38 | |||
| Day High | $286.41 | P/E | N/A | |||
| Day Low | $286.41 | EPS | $-1.45 | |||
| Volume | 549 | |||||
